Join to View Full Profile
118 Northport AveBelfast, ME 04915
Phone+1 207-930-6741
Dr. Hurwitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a retired Transplant/Vascular Surgeon living in Maine for 6 months (the good ones) and Virginia Beach for the other 6
Education & Training
Baylor University Medical CenterResidency, Thoracic Surgery - Independent, 1974 - 1975
University of ColoradoResidency, Surgery, 1968 - 1972
Johns Hopkins University School of MedicineInternship, Transitional Year, 1967 - 1968- Johns Hopkins UniversityResidency, Surgery, 1966 - 1967
- Johns Hopkins University School of MedicineClass of 1967
Certifications & Licensure
ME State Medical License 2007 - 2026
VA State Medical License 1976 - 2012
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 1 citationsInhibitors of metalloprotease, γ-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replicationAlice Liu, Cristhian J Ildefonso, Wesley S. Bond, Mary Y. Hurwitz, Richard L. Hurwitz
Plos One. 2020-07-22 - 4 citationsNovel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose‐prediction equation to determine maximum tolerated dose o...Alex George, Bogdan Dinu, Norma Estrada, Charles G. Minard, Richard L. Hurwitz
American Journal of Hematology. 2020-05-30 - 4 citationsVersican G1 Domain Enhances Adenoviral-Mediated Transgene Expression and Can Be Modulated by Inhibitors of the Janus Kinase (JAK)/STAT and Src Family Kinase PathwaysPatricia Y. Akinfenwa, Wesley S. Bond, Cristhian J Ildefonso, Mary Y. Hurwitz, Richard L. Hurwitz
The Journal of Biological Chemistry. 2017-09-01
Grant Support
- Phase I Study Of Adv/Rsv-Tk Followed By Ganciclovir For RetinoblastomaNational Center For Research Resources2004–2005
- Gene Therapy For RetinoblastomaNational Cancer Institute2002–2003
- Cyclic GMP Receptors In The RetinaNational Eye Institute1991–1995
- Cyclic GMP Binding Receptors In The RetinaNational Eye Institute1986–1988
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
